Reference record
Kidney Precision Medicine Project (KPMP) - COVID-19 Protocol
NCT05384899
First Published (first received 2022 May 20)https://clinicaltrials.gov/show/NCT05384899 (https://clinicaltrials.gov/show/NCT05384899)
Trial registry recordNo Results
Since its inception, KPMP has developed sophisticated protocols for collection and analysis
of human kidney tissue, and for collection of biofluids. Members of the consortium have
wide-ranging expertise in conducting clinical studies, processing kidney tissue, advanced
structural and molecular analysis and complex bioinformatics analysis, which will be used to
leverage effectively as a group to better understand kidney disease.
This joint protocol aims to synergize the COVID-19 study efforts of KPMP academic research
centers, to collectively study COVID-19, including its renal presentation using kidney tissue
and/or biofluids from patients suffering from COVID-19. This will increase the breadth and
depth of data available to the public to expedite discoveries, identify therapeutics, and
improve outcomes for patients with COVID-19. It will additionally bring the expertise of KPMP
investigators to bear against this pandemic